Navigation Links
Zebra 140xiIII Barcode Printer

ProductsZebra 140xiIII Barcode Printer
Company InfoLogix, Inc.
Item Zebra 140xiIII Barcode Printer
Features 
  • Handles everything from paper to specialty label/tag stocks
  • Satisfies high-volume media requirements
  • Offers fastest print speed available
  • Offers a wide range of connectivity solutions
    Description The 140XiIII is the fastest barcoding printer in the Zebra Xi Series. With such powerful performance and steel construction, it is the ideal choice for high-volume, mission-critical applications with 24-hour duty cycles. The 140XiIII is also well-suited for applications in which labels are required quickly, either on demand or in batches.
    Info InfoLogix, Inc.
    Customer Service: 215-604-0691
    Web site: http://www.infologixsys.com

    Related medicine products :

    1. Zebra
    2. Zebra H 2824-Z Healthcare Starter Kit
    3. Zebra Barcode Wristbands
    4. Zebra 105SL Cutting Edge Barcode Printer Network Connectivity
    5. Zebra Printer 220xiIII
    6. Zebra 90xiIII Printers
    7. Zebra 96xiIII Barcode Printer
    8. Patient Wristband Printer: Zebra H 2824-Z
    9. SureSight Autorefractor with Printer, Stand, and Case (English)
    10. FingerPrint Sleep Hand-Held Pulse Oximeter/Summary Printer
    11. FingerPrint Pulse Oximeter w/Printer
    For the quantitative determination of Magnesium in serum. Linearity: 4.0 mEq/L. Working Reagent prepared by simple 1:10 dilution.
    For the quantitative determination of total glucose in serum.
    Glucose reagent is used for the quantitative determination of glucose in human serum.
    Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L). Single vial, dry powder reagent.
    Medicine Products:
    (Date:11/21/2008)...y lead to new therapies for preterm labor , ...ers say they,ve found the switch that activates th...h, a finding that may lead to therapies for preter...binds the protein IP on the surface of these uteri...during pregnancy. , But researchers from Dartm...
    (Date:11/21/2008)...eting of shareholders to be held on January 8, 200...l/ - Med-Emerg International Inc. ("MedEmerg") (OT...ealth services, announced today that it has obtain...t of Justice concerning its previously announced p... which AIM Health Group Inc. ("AIM") will acquire ...
    (Date:11/21/2008)...ov. 21, 2008)The University of Texas Health Scienc...ining Excellence in Aging Studies (TEXAS), to prom...restigious $2 million award from the Donald W. Rey...ds., "This will allow us to teach geriatric medic...dical student to practicing physicians. With the r...
    (Date:11/21/2008)...Colo., Nov. 21 Heska Cor...l present at the New York Society of,Security Ana...nference on,December 2, 2008 at 1177 Avenue of th...tation is scheduled to begin at 9:35 a.m. Eastern ...ble via live webcast and for two weeks,following ...
    Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4
    ...Crawford, the former commissioner of the Food and ...l investigation following accusations of financial...s mentioned that a grand jury had begun a criminal... is believed to have told a federal magistrate, in...
    ... Spinal Meningitis (CSM) has claimed five lives af...oto State. // A parallel outbreak of measles has a...of lives. The five dead persons were among the fou...be suffering from the CSM infections. The state m...
    ...earchers at Emory University School of Medicine in...tted images are very efficient in the evaluation o...d and its accuracy of diagnosis is incomparable. ...the MDCTs of 50 patients referred for GI tract ima...
    ...so have become victims to disorders like anorexia ... But a UK study showed that 500 teenagers are affe...iends. The research is published in the British Jo... analyze the gap in the literature and look at wha...
    Other Medicine News:
    (Date:11/19/2008)... -- Biotech scientists increasingly are applying g...ter understand the effects of novel drug candidate...Engineering & Biotechnology News ( GEN ). The...compound,s mechanism of action and eventually deve...g to the November 15 issue of GEN . ( http://www....
    (Date:11/18/2008)...l/ -- NeuroDiscovery Ltd (ASX:,NDL), a specialty ... Company,and Sosei Group Corporation ("Sosei"; T...biopharmaceutical company, today announce that Neu...nical efficacy data for NSL-043/SD118.,This inves...thic pain and has,successfully completed Phase I ...
    (Date:11/18/2008)...wswire/ -- Forty-two leading U. S. scientists and ...to consider cutting-edge innovations that may defe...om outbreaks of dangerous zoonotic diseases, the F... innovations: , , , , A "Doc in...ts highly contagious and dangerous zoonotic diseas...
    (Date:11/13/2008)...FirstCall/ -- Hologic, Inc.,(Nasdaq: HOLX ), a le...ium,diagnostics, medical imaging systems and surgi...eeds of women, today announced the results of the,... Cervista HPV high-risk,test is currently under re...launched in the European Union (EU) early in 2009....
    Breaking Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4Bioenvision Shareholders Approve Acquisition by Genzyme Corporation 4322 1Bioenvision Shareholders Approve Acquisition by Genzyme Corporation 4322 2Bioenvision Shareholders Approve Acquisition by Genzyme Corporation 4322 3Bioenvision Shareholders Approve Acquisition by Genzyme Corporation 4322 4Committee to Reduce Infection Deaths Releases 10 Lifesaving Steps to Protect Students from MRSA Infections 4317 1Committee to Reduce Infection Deaths Releases 10 Lifesaving Steps to Protect Students from MRSA Infections 4317 2Abbott Announces Positive One Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 599 1Abbott Announces Positive One Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 599 2Abbott Announces Positive One Year Results from the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent 599 3drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 1drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 2drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 3drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 4drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 5drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 6drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 7drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 8drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 9drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 10drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 11drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 12drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 13drugstore com inc Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007 4311 14
    ... 25, 2007 - ARIAD,Pharmaceuticals, Inc. (NASDAQ: A...rom leading cancer centers will present Phase 2 an...any,s novel mTOR,inhibitor, AP23573, at the annual...ogy (ASCO) in Chicago, Illinois, on Sunday, June,3...single-agent,AP23573 in patients with soft-tissue ...
    ...wswire-FirstCall/ -- Iomai,Corporation today annou...1 trial of its patch-based needle-free influenza v...nce call and live,webcast will be held at 8:30 a.m...Conference Call Details , To access the live confe...rn Time via phone, please dial 888-396-2356 from t...
    Other Medicine Technology:Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 2Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 3Clinical Data on ARIAD's Novel mTOR Inhibitor, AP23573, To Be,Presented at the ASCO Annual Meeting 4Iomai to Announce Results From Phase 1 Influenza Trial and Host,Webcast Tomorrow 2